BioBlast w/e 15 Dec 23
Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…
South Korea Lendava Lendva Samsung Biologics Biomed Nona Biosciences Nona Biosciences Genentech Avastin
Source: lexology.com